HIV drug can improve vision in patients with common diabetes complication (IMAGE)
Caption
“An oral drug that improves vision in DME [diabetic macular edema] would be a game changer because it would be more convenient for patients than frequent, often monthly, injections into the eye,” said researcher Jayakrishna Ambati, MD, founding director of UVA Health’s Center for Advanced Vision Science. “The mechanism of action of lamivudine is also different from that of existing treatments, so we could also develop combination therapies.”
Credit
UVA Health
Usage Restrictions
May be used to accompany news coverage of the DME trial. All other uses require express written permission from UVA Health.
License
Original content